Bio-Gene Technology (ASX:BGT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Bio-Gene Technology (ASX:BGT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Date of 2026 Annual General Meeting
Flavocide efficacy results against deer ticks published
Corporate Governance Statement
Appendix 4G
Appendix 4E and 2026 Annual Report
Bio-Gene reports reduced loss and advances insecticide development with new capital raise
Change in substantial holding
Change in substantial holding
Notification regarding unquoted securities - BGT
Change of Director's Interest Notice x 4
Placement Completed and Cleansing Notice
Bio-Gene completes A$3.275 million placement and issues options
Application for quotation of securities - BGT
Application for quotation of securities - BGT
Application for quotation of securities - BGT
Results of Meeting
Quarterly Activities/Appendix 4C Cash Flow Report
Bio-Gene expands mosquito control programs in Asia, secures US patent, raises $3.275M